An innovative computer-aided solution for diagnosis of prostate cancer from ultrasound scans will be launched in the UK through urolology ultrasound specialist BK Medical UK Ltd.
Belgian company Advanced Medical Diagnostics SA (AMD) has appointed BK Medical UK Ltd as sole agent for its Prostate HistoScanning solution in the UK.
HistoScanning is a tissue characterisation technology based on analysis of ultrasound. It is designed to support doctors in diagnosis and treatment decisions. Prostate HistoScanning, already available in Europe, supports the diagnosis and management of prostate cancer.
As the UK agent for Prostate HistoScanning, BK Medical will be responsible for day-to-day management of sales and providing service support.
Advanced Medical Diagnostics SA and BK Medical UK Ltd have been working together to commercialise Prostate HistoScanning since its launch in 2008. BK has helped to place the systems in four major UK teaching hospitals, including Charing Cross Hospital in London.
Toby Hamblin, VP Sales of AMD, commented: “BK Medical, with its strong base in ultrasound urology in the UK, is very well placed to help us realise the full potential of Prostate HistoScanning and to provide the NHS and private clinics alike with the service and support that they, and this exciting new technology, deserve.”
Geoff Pick, Managing Director of BK Medical UK Ltd, added: “Prostate HistoScanning is an important product for us here in the UK and will help us maintain our position at the forefront of innovation in urology ultrasound technology. We are delighted that we will be able to provide our customers with this important technology and look forward to providing HistoScanning customers with the same excellent level of service that our current ultrasound users enjoy.”